| Symbol | HYFT |
|---|---|
| Name | IMMUNOPRECISE ANTIBODIES LTD. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 823 CONGRESS AVE,SUITE 300, AUSTIN, Texas, 78701, United States |
| Telephone | +1 (800) 620-4187 |
| Fax | — |
| — | |
| Website | https://www.ipatherapeutics.com/ |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001715925 |
| Description | ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - MindWalk Holdings Corp. <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001041885-26-000005 <b>Size:</b> 7 KB
Read moreMindWalk Holdings Corp. publie ses résultats financiers du troisième trimestre 2026
Read moreMindWalk présente B Cell Llama™, une plateforme de découverte de nanocorps conçue à lère des anticorps bispécifiques et de la thérapie cellulaire
Read moreMindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era
Read more